Tsrl, Inc.
Ann Arbor, MI Doing business as Therapeutic Systems Research Laboratories
- UEI
- TP74UMNGJDJ1
- CAGE
- 02NM7
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 540 Avis Dr a, Ann Arbor, MI 48108, USA
- Website
- tsr-labs.com
- Founded
- 1986
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Tsrl, Inc.
Tsrl, Inc., doing business as Therapeutic Systems Research Laboratories, is a for-profit, woman-owned small business corporate entity located in Ann Arbor, Michigan, specializing in pharmaceutical research and development. Registered in SAM.gov since 2001, the company focuses on developing innovative therapeutic solutions for complex medical conditions, with a particular emphasis on novel drug delivery systems and combination therapies. The organization is primarily engaged in scientific research and development, utilizing advanced pharmaceutical technologies to address unmet medical needs across various disease domains.
The company has received multiple federal grant awards from prestigious National Institutes of Health (NIH) institutes, including the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development, National Heart Lung and Blood Institute, and National Institute of General Medical Sciences. These grants have supported critical research initiatives in diverse medical areas, such as developing a zanamivir transdermal system for influenza treatment, creating a microneedle delivery method for trospium chloride to address overactive bladder disease, investigating a novel heparin reversal agent, and developing synthetic high-density lipoproteins for sepsis treatment. Each project demonstrates Tsrl's commitment to innovative drug delivery technologies, focusing on improving patient outcomes through advanced pharmaceutical research. The grants, ranging from cooperative agreements to project grants, typically involve Phase 1 clinical trials, preclinical research, and proof-of-concept studies aimed at advancing potential therapeutic interventions for significant health challenges.
Quick answers
What is Tsrl, Inc.'s UEI?
Tsrl, Inc.'s Unique Entity ID (UEI) in SAM.gov is TP74UMNGJDJ1.
What is Tsrl, Inc.'s CAGE code?
Tsrl, Inc.'s CAGE code is 02NM7.
Where is Tsrl, Inc. located?
Tsrl, Inc.'s physical address in SAM.gov is 540 Avis Dr a, Ann Arbor, MI 48108, USA.
Is Tsrl, Inc. registered in SAM.gov?
Yes. Tsrl, Inc.'s SAM.gov registration is active through October 5, 2027.
What is Tsrl, Inc.'s most recent federal award?
Tsrl, Inc.'s most recent federal grant award is Optimized zanamivir microarray patch (map) formulation for single application treatment of the flu (R43IP001280), from Office of Financial Resources, on September 30, 2026.
On GovTribe
See Tsrl, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors